Lupus & antiphospholipid syndrome
Characteristics of systemic lupus erythematosus (SLE) patients with symptomatic COVID-19: Single centre experience at Sultan Qaboos University Hospital over a 30-month period
Authors' conclusion
A significant difference between COVID-infected and uninfected groups was seen in the SLE disease activity and whether lung was involved in the SLE patients.
Study context
- Population
- Patients with SLE, Sultan Qaboos University Hospital, Oman, 24 February 2020 to end of July 2022
- Participants
- 352 patients
- Exposure
- COVID-infected vs non-infected SLE patients
- Outcome
- COVID-19 infection in SLE patients
- Follow-up
- 30-month period
Methodological detailsobservational, single-centre, Data from electronic medical records and patient questionnaires (OPD or phone)
- Observational
- Single-centre
- Data from electronic medical records and patient questionnaires (OPD or phone)
Main finding
As reported in the abstract
SLE patients who developed COVID-19 infection
40.6%
Mean age of infected patients
37 years
Observational data: associations, not effects.
Further findings
COVID-19 symptoms
- Myalgia/arthralgia
- 94%
- Sore throat and cough present in almost all patients
- Fever (next most common)
Original publication
Characteristics of SLE patients with symptomatic COVID-19: Single centre experience at Sultan Qaboos University Hospital over a 30-month period. Lupus. Published 20 July 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →